Author

S. Fröhling

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 3 Research Focus:drug response / drug discovery· 3 Organism:human· 3 Approach:statistical model· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:gene regulatory network inference· 2 Approach:deep learning· 1

Frequent Co-Authors

A. Mock· 1 shared A. Stenzinger· 1 shared A. Uvarovskii· 1 shared B. Brors· 1 shared B. Chapuy· 1 shared B. Goeppert· 1 shared B. Obermayer· 1 shared C. Erkut· 1 shared

Activity by Year

2019-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 13 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Mock

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Shallow nanopore RNA sequencing enables transcriptome profiling for precision cancer medicine

A. Mock, M. Braun, C. Scholl, S. Fröhling, C. Erkut

This study evaluates shallow nanopore RNA sequencing for transcriptome profiling in cancer, showing it is rapid, cost-effective, and comparable to Illumina for key analyses.

bioRxiv · May 31, 2022Cancer Biology

Dissecting intratumor heterogeneity of nodal B cell lymphomas on the transcriptional, genetic, and drug response level

T. Roider, J. Seufert, A. Uvarovskii, F. Frauhammer, M. Bordas, N. Abedpour, M. Stolarczyk, J.-P. Mallm, S. Rabe, P.-M. Bruch, H. Balke-Want, M. Hundemer, K. Rippe, B. Goeppert, M. Seiffert, , S. Dietrich

This study examines intratumor heterogeneity in B cell lymphomas by analyzing transcriptional, genetic, and drug response profiles across malignant subclones and immune cells.

bioRxiv · Dec 11, 2019Cancer Biology

Distinct immune evasion in APOBEC-enriched, HPV-negative HNSCC

C. Messerschmidt, B. Obermayer, K. Klinghammer, S. Ochsenreither, D. Treue, A. Stenzinger, H. Glimm, S. Fröhling, T. Kindler, C. H. Brandts, K. Schulze-Osthoff, W. Weichert, I. Tinhofer, F. Klauschen, U. Keilholz, , D. T. Rieke

The paper identifies an APOBEC-enriched subgroup of HPV-negative HNSCC with distinct immunogenic features linked to immune evasion and potential response to immunotherapy.

bioRxiv · Mar 28, 2019Cancer Biology